Mesa Laboratories Inc (MLAB)
Cash ratio
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | — | 28,214 | 32,910 | 49,346 | 263,865 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | — | 44,312 | 43,359 | 48,055 | 32,583 |
| Cash ratio | — | 0.64 | 0.76 | 1.03 | 8.10 |
March 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($—K
+ $—K)
÷ $—K
= —
The cash ratio of Mesa Laboratories Inc has shown a downward trend over the years, indicating a decrease in the company's ability to cover its short-term liabilities with cash and cash equivalents.
As of March 31, 2021, the cash ratio was high at 8.10, suggesting a strong ability to meet short-term obligations solely from cash on hand.
However, by March 31, 2025, the cash ratio data is unavailable (indicated by "—"), which could imply a potential liquidity concern or a shift in the company's financial strategy.
Overall, the decreasing trend in the cash ratio from 2021 to 2024 signals that Mesa Laboratories Inc may have been using its cash reserves for investments, acquisitions, or other business activities, potentially affecting its liquidity position in the short term.
Peer comparison
Mar 31, 2025